600613 神奇制药
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.9521.6333.0392.4452.079
总资产报酬率 ROA (%)0.7261.2222.2331.7101.486
投入资产回报率 ROIC (%)0.8811.4672.7122.1241.781

边际利润分析
销售毛利率 (%)43.99745.10947.52749.93252.904
营业利润率 (%)4.5433.7814.4743.5392.757
息税前利润/营业总收入 (%)4.4923.7894.5124.0303.161
净利润/营业总收入 (%)3.0072.0403.2252.4892.022

收益指标分析
经营活动净收益/利润总额(%)160.967143.072141.661167.224124.696
价值变动净收益/利润总额(%)-9.8625.0001.4102.0482.792
营业外收支净额/利润总额(%)-3.865-4.152-4.6690.682-4.149

偿债能力分析
流动比率 (X)2.9402.6643.0062.5832.286
速动比率 (X)2.5232.3462.5762.2292.003
资产负债率 (%)18.12923.77022.11327.10229.954
带息债务/全部投入资本 (%)3.2158.6709.13510.04613.696
股东权益/带息债务 (%)2,972.0051,036.382982.834883.118621.512
股东权益/负债合计 (%)436.326310.374342.964262.766229.432
利息保障倍数 (X)37.99323.77918.9868.6376.155

营运能力分析
应收账款周转天数 (天)65.66459.34562.91057.99461.508
存货周转天数 (天)76.60071.52378.89370.90367.837